Biomanufacturing Specialty Chemicals 2027-2037: Technologies, Forecasts, Markets, Players

Industrial biomanufacturing of specialty chemicals used in food, cosmetics, pigments, and enzymes. Technology benchmarking and trends in synthetic biology and fermentation-based production. Market outlook, players, and 10-year forecasts of 28 chemicals.

Show All Description Contents, Table & Figures List FAQs Pricing Related Content
Key aspects of this report
This report provides critical market intelligence about biomanufactured specialty chemicals across food, cosmetics, pigments, and enzymes. This includes:
  • A review of the context and technology behind industrial biomanufacturing for specialty chemicals
  • History and context for each subsector: food additives, beauty & personal care, pigments, and enzymes
  • General overview of important technologies such as microbial fermentation, synthetic biology, and cell-free systems
  • Overall look at specialty chemical trends and themes within biomanufacturing, including sustainability, regulation, and consumer demand
  • Benchmarking and analysis of different players throughout, including startups, incumbents, and synthetic biology companies
  • Full market characterization for each major product area, with segment-specific dynamics and growth constraints
  • Review of the food additives landscape, including amino acids, vitamins, flavor enhancers, and sweeteners
  • Review of the cosmetics and personal care sector, including hyaluronic acid, recombinant collagen, vanillin, nootkatone, and novel bioactives
  • Review of industrial and bioenergy enzymes, including their roles in detergents, textiles, pulp and paper, leather, biofuels, and decarbonization
  • Reviews of pigments and colorants produced via biomanufacturing, with focus on scalability and performance advantages
  • Market analysis, including demand drivers, regulatory context, and technology readiness levels (TRLs)
  • Review of companies active in specialty chemicals biomanufacturing, profiled across regions and applications
  • Market size and capacity forecasts from 2027 to 2037 for 28 chemicals, including full narrative, limitations, and methodologies
Report description
Specialty chemicals underpin a wide range of high-performance products, from advanced food formulations and cosmetic actives to industrial catalysts and functional coatings. Unlike commodity chemicals such as fuels and plastic precursors, they are defined not by volume but by their ability to deliver precise functions, meet strict regulatory requirements, and achieve consistent purity and performance. Even minor variations in their formulation can determine whether a product succeeds or fails in the market, making their production technically demanding and strategically important. Specialty chemicals serve narrower markets, command higher margins, and can justify more complex or precise production methods.
 
Industrial biomanufacturing (also known as white biotechnology, industrial biotechnology, and bioindustrial manufacturing) uses living microorganisms and enzymes to produce commercial materials and chemicals using renewable feedstock. It is uniquely suited to specialty chemicals production since it can access complex or chiral molecules that are challenging to synthesize via petrochemical routes, reduce greenhouse gas emissions, and minimize hazardous by-products. Advances in synthetic biology, strain engineering, and alternative feedstocks are making biomanufacturing economically viable and even competitive for a growing range of specialty chemicals, unlocking new commercial opportunities.
 
Products of Industrial biomanufacturing
Products of industrial biomanufacturing. Source: IDTechEx
 
The IDTechEx report, Biomanufacturing Specialty Chemicals 2027-2037: Technologies, Forecasts, Markets, Players, examines the role of industrial biomanufacturing in producing specialty chemicals, focusing on food additives, cosmetic and personal care ingredients, pigments, and enzymes. Its coverage of enzymes spans several industrial applications, from bioenergy to decarbonization and recycling. The report evaluates market drivers, technology developments, commercial challenges, and the competitive landscape shaping the sector's future.
 
Industrial biomanufacturing for a resilient bioeconomy
The bioeconomy is an economic system built on the use of renewable biological resources derived from agriculture, fisheries, and forestry to produce food, materials, chemicals, and energy. Because these resources can often be sourced close to where they are grown or processed, the bioeconomy offers a path to a more resilient, sustainable economic model, one less exposed to the long, fragile supply chains that have repeatedly disrupted the materials and chemicals industry. That vulnerability is sharpened by the sector's continued dependence on globally traded fossil fuels, making the case for biobased alternatives more urgent than ever.
 
Industrial biomanufacturing is vital to building this resilient bioeconomy. As a key technology enabler, it allows specialty and novel chemicals to be produced through biological systems running on renewable, locally sourced feedstocks, which shorten supply chains, reduce exposure to volatile international markets, and keep more economic value within local and regional economies.
 
Why specialty chemicals?
Although industrial biomanufacturing has been utilized for decades, from bacterial enzymes in detergents to fermented food additives, recent technological advances have rapidly expanded its applications in specialty chemicals. In addition, regulatory pressures, corporate sustainability commitments, and consumer demand for bio-based products are creating favorable conditions for adoption.
 
Specialty chemicals represent a strategic growth area for industrial biomanufacturing. Many of these products have established markets but rely on supply chains that face sustainability pressures, sourcing constraints, or cost volatility. Others are niche ingredients where existing production routes are inefficient or poorly scalable.
 
For companies developing biomanufacturing capabilities, specialty chemicals markets offer an opportunity to commercialize products at smaller scales while still achieving viable profitability. In addition, the fragmented nature of specialty markets allows smaller producers to establish competitive positions without immediately competing head-to-head with the largest chemical companies on bulk output.
 
Technological advances driving biomanufacturing
The specialty chemicals sector is benefiting from rapid advances in synthetic biology, which is enabling engineered biocatalysts with improved yield, stability, and specificity. Alternative feedstocks such as lignocellulosic biomass, waste gases, and agricultural by-products are creating new pathways for production. Novel biocatalysts are expanding the range of accessible molecules, while carbon-neutral and carbon-negative production routes are emerging as part of wider decarbonization efforts. Cell-free systems are making it possible to produce high-value molecules without the limitations of whole-cell fermentation. Advances in strain optimization and metabolic engineering are increasing productivity and reducing downstream processing costs. Together, these technology trends are opening new opportunities for specialty chemicals markets and enabling products that were previously not technically or economically viable. IDTechEx's latest report examines these advances, profiling the technologies and companies that are shaping the future of biomanufacturing for specialty chemicals.
 
Market drivers, challenges, and economic viability
Demand for sustainable, bio-based chemicals is rising due to consumer preferences, brand commitments, and tightening regulations, particularly in food and cosmetics. However, economic viability remains a decisive consideration. Internal factors such as process yield, scalability, and choice of biocatalyst can determine whether a project succeeds commercially. Other factors include oil price volatility, regulatory frameworks, and customers' willingness to pay a green premium. Suppliers also face lengthy regulatory approval processes and fragmented markets that require engagement with multiple niche applications. This report examines how companies are addressing these barriers, with case studies of both successful and unsuccessful attempts to scale biomanufacturing.
 
Scope of this report
This IDTechEx report focuses on the specialty chemicals segment of industrial biomanufacturing. It profiles key specialty molecules in detail, describing for each the production process and key biocatalysts, technical advantages over petrochemical or extracted equivalents, current challenges, downstream applications, and technology readiness level. The report includes 10-year forecasts of global production capacity and market size of 28 biomanufactured specialty chemicals from 2027 to 2037. The molecules are segmented into 4 major categories: cosmetics & personal care, food additives, enzymes, and pigments & colorants. Biomanufactured fuels, plastic precursors, and other commodity chemicals are discussed in our companion report: Industrial Biomanufacturing 2027-2037: Technologies, Markets, Players, Forecasts.
Report MetricsDetails
CAGRBiomanufactured specialty chemicals market size to grow at a CAGR of 5.9% from 2027 to 2037.
Forecast Period2027 - 2037
Forecast Unitskilotonnes per annum (ktpa), US$ millions
Regions CoveredWorldwide
Segments Covered-Cosmetics and personal care (emollients & moisturizers, biosurfactants, fragrances, skin actives & repair) -Food additives (amino acids, vitamins, thickeners & stabilizers, flavor enhancers, sweeteners) -Enzymes (for food & beverage, detergents, biofuel production, and other industrial applications) -Pigments and colorants (carotenoids, blue & violet pigments, red pigments, and melanin)
Analyst access from IDTechEx
All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.
Further information
If you have any questions about this report, please do not hesitate to contact our report team at research@IDTechEx.com or call one of our sales managers:

AMERICAS (USA): +1 617 577 7890
ASIA (Japan and Korea): +81 3 3216 7209
EUROPE (UK) +44 1223 812300
1.EXECUTIVE SUMMARY
1.1.What is industrial biomanufacturing?
1.2.Biomanufacturing Specialty Chemicals 2027-2037: Scope
1.3.Market trends and drivers in industrial biomanufacturing (1)
1.4.Market trends and drivers in industrial biomanufacturing (2)
1.5.Synthetic biology as applied to industrial biomanufacturing
1.6.Technology trends in industrial biomanufacturing
1.7.Overview of alternative feedstocks for industrial biomanufacturing
1.8.Major market challenges for industrial biomanufacturing
1.9.Technical challenges for industrial biomanufacturing
1.10.Products derived from industrial biomanufacturing: Overview
1.11.Specialty chemicals that can be produced by industrial biomanufacturing
1.12.Company landscape in biomanufacturing specialty chemicals
1.13.Biomanufactured fragrances and aromatics: Emerging company landscape
1.14.Other emerging biomanufactured beauty products and status
1.15.Technology Readiness Level (TRL): Cosmetics & personal care
1.16.Biosurfactants: Company landscape
1.17.Technology challenges and opportunities for bioenergy enzymes
1.18.Technology Readiness Level (TRL): Enzymes for bioenergy applications
1.19.Cost-performance metrics for thermostable enzymes
1.20.Technology readiness levels of enzyme applications in bioenergy
1.21.Selected enzymatic approaches to CO2 capture and conversion
1.22.Technology Readiness Level (TRL): Sweeteners
1.23.Technology Readiness Level (TRL): Biomanufactured pigments
1.24.Biomanufactured specialty chemicals overall market forecast 2027-2037
1.25.Biomanufactured specialty chemicals overall market forecast 2027-2037: Market share
1.26.Industrial biomanufacturing for commodity chemicals 2027-2037
1.27.Access More With an IDTechEx Subscription
2.INTRODUCTION
2.1.Introduction to specialty chemicals
2.2.Biotechnology application
2.3.What is industrial biomanufacturing?
2.4.The bioeconomy and industrial biomanufacturing
2.5.Precision fermentation: Definition and scope
2.6.Biomanufacturing Specialty Chemicals 2027-2037: Scope
2.7.Products derived from industrial biomanufacturing: Overview
2.8.Molecules that can be produced through biomanufacturing: Cosmetics
2.9.Molecules that can be produced through biomanufacturing: Food additives
2.10.Molecules that can be produced through biomanufacturing: Enzymes (1)
2.11.Molecules that can be produced through biomanufacturing: Enzymes (2)
2.12.Molecules that can be produced through biomanufacturing: Pigments
2.13.Company landscape in biomanufacturing specialty chemicals (1)
2.14.Company landscape in biomanufacturing specialty chemicals (2)
2.15.Market trends and drivers in industrial biomanufacturing (1)
2.16.Market trends and drivers in industrial biomanufacturing (2)
3.MARKET ANALYSIS
3.1.Market Drivers for Industrial Biomanufacturing
3.2.Market drivers: Demand for biobased products
3.3.Market drivers: Government support of biomanufacturing
3.4.Market drivers: Carbon taxes
3.5.Economic Viability of Industrial Biomanufacturing
3.6.Factors affecting the economic viability of industrial biomanufacturing projects
3.7.Effect of the price of Brent crude on biobased products
3.8.The Green Premium
3.9.The effect of biomass feedstock prices on the bioplastics market
3.10.Effect of cell factory on cost
3.11.How scale-up affects cost
3.12.Zymergen: Case study on economics of synthetic biology
3.13.Case study: LanzaTech
3.14.Case study: Solazyme
3.15.Synthetic biology: Shift from commodity products to lower volume, high value markets
3.16.Major market challenges for industrial biomanufacturing
4.CELL FACTORIES FOR INDUSTRIAL BIOMANUFACTURING
4.1.Cell factories for biomanufacturing: Factors to consider
4.2.Cell factories for biomanufacturing: A range of organisms (1)
4.3.Cell factories for biomanufacturing: A range of organisms (2)
4.4.Escherichia coli (E.coli)
4.5.Corynebacterium glutamicum (C. glutamicum)
4.6.Bacillus subtilis (B. subtilis)
4.7.Saccharomyces cerevisiae (S. cerevisiae)
4.8.Yarrowia lipolytica (Y. lipolytica)
4.9.Purple bacteria: Introduction
4.10.Purple bacteria: Applications and outlook
4.11.Purple bacteria: SWOT analysis
4.12.Purple bacteria case study: Symbiobe
4.13.Non-model organisms for industrial biomanufacturing
5.TECHNOLOGY DEVELOPMENTS
5.1.Synthetic biology
5.1.1.Synthetic biology: The design and engineering of biological systems
5.1.2.Synthetic biology: Manipulating the central dogma
5.1.3.The vast scope of synthetic biology
5.1.4.The process of synthetic biology: Design, build and test
5.1.5.Synthetic biology: Why now?
5.1.6.Synthetic biology: From pharmaceuticals to consumer products
5.1.7.Synthetic biology: Disrupting existing supply chains
5.1.8.Synthetic biology: Drivers and barriers for adoption
5.1.9.Synthetic biology as applied to industrial biomanufacturing
5.1.10.Tools and Techniques of Synthetic Biology
5.1.11.Tools and techniques of synthetic biology: Overview
5.1.12.DNA synthesis
5.1.13.Introduction to CRISPR-Cas9
5.1.14.CRISPR-Cas9: A bacterial immune system
5.1.15.CRISPR-Cas9's importance to synthetic biology
5.1.16.Protein/enzyme engineering
5.1.17.Computer-aided design
5.1.18.Commercial examples of engineered proteins in industrial applications
5.1.19.Strain construction and optimization
5.1.20.Synergy between synthetic biology and metabolic engineering
5.1.21.Framework for developing industrial microbial strains
5.1.22.The problem with scale
5.2.Cell-free biomanufacturing
5.2.1.Introduction to cell-free systems
5.2.2.Cell-free versus cell-based systems
5.2.3.Cell-free systems in the context of industrial biomanufacturing
5.2.4.Cell-free systems for industrial biomanufacturing
5.2.5.Commercial implementation of cell-free systems: Solugen
5.2.6.Startups pursuing cell-free systems for industrial biomanufacturing (1)
5.2.7.Startups pursuing cell-free systems for industrial biomanufacturing (2)
5.2.8.Immobilized enzymes in industrial biomanufacturing (1)
5.2.9.Immobilized catalysts in industrial biomanufacturing (2)
5.3.Improvement of biomanufacturing processes
5.3.1.Continuous vs batch biomanufacturing
5.3.2.Continuous perfusion bioreactors
5.3.3.Benefits and challenges of continuous biomanufacturing
5.3.4.Continuous vs batch biomanufacturing: Key fermentation parameter comparison
5.3.5.Continuous fermentation: DAB.bio
5.3.6.Simultaneous saccharification and fermentation (SSF)
5.3.7.Sterility-free fermentation
5.3.8.Hybrid biotechnological-chemical approaches
5.3.9.Process intensification and high-cell-density fermentation
5.3.10.Submerged liquid fermentation bioreactors (1)
5.3.11.Submerged liquid fermentation bioreactors (2)
5.3.12.Solid state fermentation
5.3.13.Solid state fermentation bioreactors
5.3.14.Downstream processing (DSP) improvements (1)
5.3.15.Downstream processing (DSP) improvements (2)
5.3.16.Tangential flow filtration (TFF) in downstream bioprocessing
5.4.Automation and AI for biomanufacturing
5.4.1.Robotics: Enabling hands-free and high throughput science
5.4.2.Robotic cloud laboratories
5.4.3.Automating organism design and closing the loop
5.4.4.Machine learning de novo protein prediction
5.4.5.AI-driven protein/enzyme design companies
5.4.6.Machine learning to improve biomanufacturing processes
5.4.7.AI-driven fermentation platform companies
5.4.8.Overview of machine learning based improvements for biomanufacturing
5.5.Industrial biomanufacturing for sustainability
5.5.1.Industrial biomanufacturing as a sustainable technology
5.5.2.Routes for carbon capture in industrial biomanufacturing
5.5.3.Autotrophic bacteria for carbon capture through biomanufacturing
5.6.Alternative feedstocks for biomanufacturing
5.6.1.Why use alternative feedstocks for industrial biomanufacturing?
5.6.2.Food, land, and water competition
5.6.3.C1 feedstocks: Metabolic pathways
5.6.4.C1 feedstocks: Economic benefits
5.6.5.C1 feedstocks: Challenges
5.6.6.Non-methane C1 feedstocks
5.6.7.C1 feedstocks: Products
5.6.8.C1 feedstocks: Gas fermentation
5.6.9.C2 feedstocks
5.6.10.C2 feedstocks: Products segmented by feedstock
5.6.11.C1 and C2 feedstocks: Commercial activity (1)
5.6.12.C1 and C2 feedstocks: Commercial activity (2)
5.6.13.Lignocellulosic biomass feedstocks
5.6.14.Lignocellulosic biomass feedstocks: Challenges
5.6.15.Lignocellulosic biomass feedstocks: Challenges
5.6.16.Lignocellulosic biomass feedstocks: Products
5.6.17.Lignocellulosic feedstocks: Commercial activity
6.BLUE BIOTECHNOLOGY
6.1.What is blue biotechnology?
6.2.Main biocatalysts of blue biotechnology: Cyanobacteria and algae
6.3.Cyanobacteria
6.4.Algae
6.5.Key drivers and challenges for blue biotechnology
6.6.Selected startups in blue biotechnology
7.PRODUCTS DERIVED FROM INDUSTRIAL BIOMANUFACTURING
7.1.1.Products derived from industrial biomanufacturing: Overview
7.2.Cosmetics and personal care
7.2.1.Introduction
7.2.2.Biomanufacturing in the beauty sector
7.2.3.Incumbent beauty ingredient supply chain (1)
7.2.4.Incumbent beauty ingredient supply chain (2)
7.2.5.Incumbent beauty ingredient supply chain company landscape (1)
7.2.6.Incumbent beauty ingredient supply chain company landscape (2)
7.2.7.Biomanufactured beauty ingredient supply chain and processing
7.2.8.Established biotech-derived beauty ingredients
7.2.9.Emerging biotech-derived beauty ingredients
7.2.10.Challenges in the biomanufactured beauty ingredients sector
7.2.11.Fragrances and Aromatic Compounds
7.2.12.Biotech-derived fragrance precursors
7.2.13.Fragrances and aromatic compounds overview
7.2.14.Fragrances and aromatic compounds
7.2.15.Biomanufactured fragrances and aromatics: Emerging company landscape
7.2.16.Biomanufactured fragrances and aromatics: Emerging company landscape
7.2.17.Fragrances and aromatic compounds: Company landscape (1)
7.2.18.Fragrances and aromatic compounds: Company landscape (2)
7.2.19.Ambroxan
7.2.20.Biosurfactants
7.2.21.Biosurfactants: Introduction
7.2.22.Biosurfactants: Trends
7.2.23.Biosurfactants: Company landscape (1)
7.2.24.Biosurfactants: Company landscape (2)
7.2.25.Biomanufactured surfactants: Company landscape
7.2.26.Surfactants: Functional roles and market importance in industrial biomanufacturing
7.2.27.Rhamnolipids
7.2.28.Sophorolipids
7.2.29.Mannosylerythritol lipids (MELs)
7.2.30.Cellobiose lipids
7.2.31.Designer glycolipids and lipopeptides via synthetic biology
7.2.32.Polysaccharide-based amphiphiles
7.2.33.Industrial biomanufacturing surfactants commercial landscape
7.2.34.Hyaluronic Acid
7.2.35.Hyaluronic acid: Fermentation-based production for moisturizing
7.2.36.Hyaluronic acid: Fermentation-based production for moisturizing (2)
7.2.37.Function-driven customization of biotech-derived hyaluronic acid formulations
7.2.38.Function-driven customization of biotech-derived hyaluronic acid formulations
7.2.39.Hyaluronic acid technologies: Functions and key players
7.2.40.Hyaluronic acid: Company landscape (1)
7.2.41.Hyaluronic acid: Company landscape (2)
7.2.42.Hyaluronic Acid
7.2.43.Emollients
7.2.44.Squalene and Squalane: Industrial biomanufacturing alternatives to shark liver oil (1)
7.2.45.Squalene and Squalane: Industrial biomanufacturing alternatives to shark liver oil (2)
7.2.46.Squalene
7.2.47.Squalene and Squalane: Company landscape
7.2.48.Squalene and Squalane: Company landscape
7.2.49.Collagen
7.2.50.Collagen in skin and personal care products
7.2.51.Collagen in skin and personal care products
7.2.52.Collagen: Company landscape
7.2.53.Collagen: Company landscape (2)
7.2.54.Collagen: Company landscape
7.2.55.Comparison of native, hydrolyzed, and recombinant collagen structures
7.2.56.Comparison of native, hydrolyzed, and recombinant collagen structures
7.2.57.Engineered collagen derivatives with enhanced bioactivity
7.2.58.Collagen (e.g. Geltor)
7.2.59.Other products for cosmetics
7.2.60.Bio-based UV filters and photoprotective compounds
7.2.61.Case study: OneSkin - OS 01 Senotherapeutic Peptide
7.2.62.Market Analysis and Benchmarking
7.2.63.Biomanufactured beauty ingredient production capacities
7.2.64.Comparing biomanufactured and conventional products (1)
7.2.65.Comparing biomanufactured and conventional products (2)
7.2.66.Comparing biomanufactured and conventional products (3)
7.2.67.Comparing biomanufactured and conventional products (4)
7.2.68.Biotech ingredients metrics comparison (1)
7.2.69.Biotech ingredients metrics comparison (2)
7.2.70.Biotech ingredient comparison metrics - IDTechEx framework (1)
7.2.71.Biotech ingredient comparison metrics - IDTechEx framework (2)
7.2.72.Outlook for biomanufactured beauty ingredients
7.2.73.General challenges for biomanufacturing in the beauty sector
7.2.74.Other emerging biomanufactured beauty products and status
7.2.75.Other emerging biomanufactured beauty products and status
7.2.76.Technology Readiness Level (TRL): Beauty products
7.2.77.Biomanufactured ingredients vs conventional alternatives
7.2.78.Biomanufactured ingredients vs conventional alternatives
7.3.Food additives
7.3.1.Vitamins
7.3.2.Vitamins produced using industrial biomanufacturing
7.3.3.Vitamin B2 (Riboflavin)
7.3.4.Vitamin B12 (Cobalamin)
7.3.5.Vitamin C (Ascorbic Acid)
7.3.6.Vitamin B7 (Biotin)
7.3.7.Vitamin B3 (Niacin / Nicotinic Acid)
7.3.8.Vitamin B9 (Folic Acid / Folate)
7.3.9.Amino Acids
7.3.10.Amino acids produced using industrial biomanufacturing
7.3.11.Lysine
7.3.12.Glutamate (Monosodium Glutamate, MSG)
7.3.13.Methionine
7.3.14.Technology Readiness Level (TRL): Food additives
7.3.15.Flavor Enhancers
7.3.16.Flavor enhancers
7.3.17.Disodium Inosinate (IMP)
7.3.18.Disodium Guanylate (GMP)
7.3.19.Sweeteners
7.3.20.Introduction to sweeteners
7.3.21.Sweeteners regional landscape
7.3.22.Biomanufacturing sweeteners: Overview
7.3.23.Rare sugars
7.3.24.Rare sugars: Commercial activity (1)
7.3.25.Rare sugars: Commercial activity (2)
7.3.26.Sugar alcohols (polyols)
7.3.27.Sugar alcohols: Commercial activity (1)
7.3.28.Sugar alcohols: Commercial activity (2)
7.3.29.High-potency sweeteners
7.3.30.High-potency sweeteners: Commercial activity (1)
7.3.31.High-potency sweeteners: Commercial activity (2)
7.3.32.Technology Readiness Level (TRL): Sweeteners
7.4.Enzymes
7.4.1.Overview
7.4.2.Overview: Industrial biomanufacturing for enzymes
7.4.3.Microbial platforms for industrial enzyme production (1)
7.4.4.Microbial platforms for industrial enzyme production (2)
7.4.5.Trends in enzyme production
7.4.6.Leading enzyme producers and technology providers
7.4.7.Enzymes for onward use: Novonesis
7.4.8.Competitive landscape of leading enzyme producers
7.4.9.Product strengths and weaknesses company comparison
7.4.10.Enzymes for Bioenergy Applications
7.4.11.Enzyme uses in biofuel production
7.4.12.Enzymes for bioenergy applications
7.4.13.Bioenergy value chain: Enzymes as enabling technologies
7.4.14.Technology Readiness Level (TRL): Enzymes for bioenergy applications
7.4.15.Technology Readiness Level (TRL): Enzymes for bioenergy applications
7.4.16.Cellulosic ethanol production overview
7.4.17.Cellulases for lignocellulosic bioethanol
7.4.18.Hemicellulases and synergistic enzyme cocktails
7.4.19.Xylanases and accessory enzymes in biomass hydrolysis
7.4.20.Amylases in first-generation bioethanol
7.4.21.Lipases for enzymatic biodiesel production
7.4.22.Oxidative enzymes (Laccases, Peroxidases) for biomass pretreatment
7.4.23.Thermostable and extremophilic enzymes for harsh processing conditions
7.4.24.Thermostable enzymes: Commercial examples and industrial applications
7.4.25.Cost-performance metrics for thermostable enzymes
7.4.26.Economic competitiveness of enzymatic bioenergy processing
7.4.27.Technology readiness levels of enzyme applications in bioenergy
7.4.28.Technology challenges and opportunities for bioenergy enzymes
7.4.29.Enzymes for Decarbonization and CO₂ Utilization
7.4.30.Enzymes as catalysts in low-carbon process development
7.4.31.Carbonic anhydrase in CO₂ capture technologies
7.4.32.Formate dehydrogenase and CO₂-to-chemicals pathways
7.4.33.Enzyme-coupled CO₂-to-Fuel or CO₂-to-chemical systems
7.4.34.Enzyme integration in CCUS
7.4.35.Barriers to commercial deployment of enzyme-based CO₂ systems
7.4.36.Selected enzymatic approaches to CO2 capture and conversion
7.4.37.Enzymes for Plastics Recycling
7.4.38.Enzymatic depolymerization overview
7.4.39.Enzymes used for plastics depolymerization (1)
7.4.40.Enzymes used for plastics depolymerization (2)
7.4.41.Enzymatic depolymerization of polyamides (nylon)
7.4.42.Challenges in enzymatic depolymerization
7.4.43.The challenges of mixed plastics for enzymatic depolymerization
7.4.44.The effect of contamination on enzyme activity
7.4.45.Companies pursuing enzyme recycling
7.4.46.SWOT analysis for enzyme recycling
7.5.Pigments and colorants
7.5.1.Introduction to pigments
7.5.2.Biomanufactured pigments: By color
7.5.3.Biomanufactured pigments: By color
7.5.4.Biomanufactured pigments: SWOT analysis
7.5.5.Carotenoids: Commercial activity
7.5.6.Blue and violet pigments: Overview
7.5.7.Blue and violet pigments: Commercial activity (1)
7.5.8.Blue and violet pigments: Commercial activity (2)
7.5.9.Red pigments: Overview
7.5.10.Red pigments: Commercial activity (1)
7.5.11.Red pigments: Commercial activity (2)
7.5.12.Melanin
7.5.13.Melanin: Commercial activity
7.5.14.Technology Readiness Level (TRL): Biomanufactured pigments
8.FORECASTS FOR BIOMANUFACTURING SPECIALTY CHEMICALS
8.1.IDTechEx Methodology
8.2.Methodology: Forecasting global capacity and market size (1)
8.3.Methodology: Forecasting global capacity and market size (2)
8.4.Biomanufactured specialty chemicals overall market 2027-2037
8.5.Biomanufactured specialty chemicals overall market 2027-2037: Capacity
8.6.Biomanufactured specialty chemicals overall market 2027-2037: Market size
8.7.Biomanufactured specialty chemicals overall market 2027-2037: Market share
8.8.Biomanufactured food, beverage & nutrition chemicals 2027-2037
8.9.Biomanufactured food, beverage & nutrition chemicals 2027-2037: Capacity
8.10.Biomanufactured food, beverage & nutrition chemicals 2027-2037: Market size
8.11.Biomanufactured cosmetics & personal care chemicals 2027-2037
8.12.Biomanufactured cosmetics & personal care chemicals 2027-2037: Capacity
8.13.Biomanufactured cosmetics & personal care chemicals 2027-2037: Market size
8.14.Biomanufactured enzymes 2027-2037
8.15.Biomanufactured enzymes 2027-2037: Capacity
8.16.Biomanufactured enzymes 2027-2037: Market size
8.17.Biomanufactured pigments and colorants 2027-2037
8.18.Biomanufactured pigments and colorants 2027-2037: Capacity
8.19.Biomanufactured pigments and colorants 2027-2037: Market size
9.COMPANY PROFILES
9.1.17Cicada
9.2.Afyren
9.3.Ambrosia Bio
9.4.Arzeda
9.5.Biomason
9.6.Biotic Circular Technologies
9.7.Bluepha
9.8.Bolt Threads
9.9.Braskem Bioplastics
9.10.CarbonBridge
9.11.Cathay Industrial Biotech
9.12.Celtic Renewables
9.13.Chaincraft
9.14.CJ Biomaterials
9.15.CyanoCapture
9.16.Danimer Scientific
9.17.Ecovative Forager
9.18.Enginzyme
9.19.Enzymaster
9.20.Fortum: INGA Plastic
9.21.Geno: 1,4-Butanediol
9.22.Geno: C6 Nylon Precursors
9.23.Henan Techuang Biotechnology
9.24.Holiferm
9.25.Huitong Biomaterials
9.26.Industrial Microbes
9.27.Kaneka: PHAs
9.28.Kraig Biocraft Laboratories
9.29.LanzaTech
9.30.Mango Materials
9.31.NatureWorks
9.32.New Energy Blue
9.33.Novozymes (now Novonesis)
9.34.Ourobio
9.35.Paques Biomaterials
9.36.Q Power
9.37.Shellworks
9.38.Solugen
9.39.Spiber
9.40.Teijin Frontier: PLA
9.41.TotalEnergies Corbion
 

About IDTechEx reports

What are the qualifications of the people conducting IDTechEx research?

Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their specialist field, and all of whom are employees. All our analysts are well-connected in their fields, intensively covering their sectors, revealing hard-to-find information you can trust.

How does IDTechEx gather data for its reports?

By directly interviewing and profiling companies across the supply chain. IDTechEx analysts interview companies by engaging directly with senior management and technology development executives across the supply chain, leading to revealing insights that may otherwise be inaccessible.
 
Further, as a global team, we travel extensively to industry events and companies to conduct in-depth, face-to-face interviews. We also engage with industry associations and follow public company filings as secondary sources. We conduct patent analysis and track regulatory changes and incentives. We consistently build on our decades-long research of emerging technologies.
 
We assess emerging technologies against existing solutions, evaluate market demand and provide data-driven forecasts based on our models. This provides a clear, unbiased outlook on the future of each technology or industry that we cover.

What is your forecast methodology?

We take into account the following information and data points where relevant to create our forecasts:
  • Historic data, based on our own databases of products, companies' sales data, information from associations, company reports and validation of our prior market figures with companies in the industry.
  • Current and announced manufacturing capacities
  • Company production targets
  • Direct input from companies as we interview them as to their growth expectations, moderated by our analysts
  • Planned or active government incentives and regulations
  • Assessment of the capabilities and price of the technology based on our benchmarking over the forecast period, versus that of competitive solutions
  • Teardown data (e.g. to assess volume of materials used)
  • From a top-down view: the total addressable market
  • Forecasts can be based on an s-curve methodology where appropriate, taking into account the above factors
  • Key assumptions and discussion of what can impact the forecast are covered in the report.

How can I be confident about the quality of work in IDTechEx reports?

Based on our technical analysts and their research methodology, for over 25 years our work has regularly received superb feedback from our global clients. Our research business has grown year-on-year.
 
Recent customer feedback includes:
"It's my first go-to platform"
- Dr. Didi Xu, Head of Foresight - Future Technologies, Freudenberg Technology Innovation
 
"Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
- Ralf Hug, Global Head of Product Management & Marketing, Marquardt

What differentiates IDTechEx reports?

Our team of in-house technical analysts immerse themselves in industries over many years, building deep expertise and engaging directly with key industry players to uncover hard-to-find insights. We appraise technologies in the landscape of competitive solutions and then assess their market demand based on voice-of-the-customer feedback, all from an impartial point of view. This approach delivers exceptional value to our customers—providing high-quality independent content while saving customers time, resources, and money.

Why should we pick IDTechEx research over AI research?

A crucial value of IDTechEx research is that it provides information, assessments and forecasts based on interviews with key people in the industry, assessed by technical experts. AI is trained only on content publicly available on the web, which may not be reliable, in depth, nor contain the latest insights based on the experience of those actively involved in a technology or industry, despite the confident prose.

How can I justify the ROI of this report?

Consider the cost of the IDTechEx report versus the time and resources required to gather the same quality of insights yourself. IDTechEx analysts have built up an extensive contact network over many years; we invest in attending key events and interviewing companies around the world; and our analysts are trained in appraising technologies and markets.
 
Each report provides an independent, expert-led technical and market appraisal, giving you access to actionable information immediately, rather than you having to spend months or years on your own market research.

Can I speak to analysts about the report content?

All report purchases include up to 30 minutes of telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

What is the difference between a report and subscription?

A subscription from IDTechEx can include more reports, access to an online information platform with continuously updated information from our analysts, and access to analysts directly.

Before purchasing, I have some questions about the report, can I speak to someone?

Please email research@idtechex.com stating your location and we will quickly respond.

About IDTechEx

Who are IDTechEx's customers?

IDTechEx has served over 35,000 customers globally. These range from large corporations to ambitious start-ups, and from Governments to research centers. Our customers use our work to make informed decisions and save time and resources.

Where is IDTechEx established?

IDTechEx was established in 1999, and is headquartered in Cambridge, UK. Since then, the company has significantly expanded and operates globally, having served customers in over 80 countries. Subsidiary companies are based in the USA, Germany and Japan.

Questions about purchasing a report

How do I pay?

In most locations reports can be purchased by credit card, or else by direct bank payment.

How and when do I receive access to IDTechEx reports?

When paying successfully by credit card, reports can be accessed immediately. For new customers, when paying by bank transfer, reports will usually be released when the payment is received. Report access will be notified by email.

How do I assign additional users to the report?

Users can be assigned in the report ordering process, or at a later time by email.

Can I speak to someone about purchasing a report?

Please email research@idtechex.com stating your location and we will quickly respond.
 

Ordering Information

Biomanufacturing Specialty Chemicals 2027-2037: Technologies, Forecasts, Markets, Players

£€$元¥₩
Electronic (1-5 users)
£7,475.00
Electronic (6-10 users)
£10,465.00
Electronic and 1 Hardcopy (1-5 users)
£8,475.00
Electronic and 1 Hardcopy (6-10 users)
£11,465.00
Electronic (1-5 users)
€8,750.00
Electronic (6-10 users)
€12,250.00
Electronic and 1 Hardcopy (1-5 users)
€9,925.00
Electronic and 1 Hardcopy (6-10 users)
€13,420.00
Electronic (1-5 users)
$9,995.00
Electronic (6-10 users)
$13,990.00
Electronic and 1 Hardcopy (1-5 users)
$11,330.00
Electronic and 1 Hardcopy (6-10 users)
$15,325.00
Electronic (1-5 users)
元67,900.00
Electronic (6-10 users)
元95,000.00
Electronic and 1 Hardcopy (1-5 users)
元76,990.00
Electronic and 1 Hardcopy (6-10 users)
元104,050.00
Electronic (1-5 users)
¥1,200,000
Electronic (6-10 users)
¥1,692,000
Electronic and 1 Hardcopy (1-5 users)
¥1,416,000
Electronic and 1 Hardcopy (6-10 users)
¥1,908,000
Electronic (1-5 users)
₩15,130,000
Electronic (6-10 users)
₩21,180,000
Electronic and 1 Hardcopy (1-5 users)
₩17,150,000
Electronic and 1 Hardcopy (6-10 users)
₩23,200,000
Click here to enquire about additional licenses.
If you are a reseller/distributor please contact us before ordering.
お問合せ、見積および請求書が必要な方はm.murakoshi@idtechex.com までご連絡ください。
Global market size of biomanufactured specialty chemicals to exceed US$8.5 billion by 2037.

Report Statistics

Slides 373
Companies 41
Forecasts to 2037
Published Nov 2026
 

Preview Content

pdf Document Sample pages
 

Customer Testimonial

quote graphic
"The resources produced by IDTechEx are a valuable tool... Their insights and analyses provide a strong foundation for making informed, evidence-based decisions. By using their expertise, we are better positioned to align our strategies with emerging opportunities."
Director of Market Strategy
Centre for Process Innovation (CPI)
 
 
 
ISBN: 9781835702055

Subscription Enquiry